SRS128 - Minimally invasive ablative techniques as the definitive treatment for primary breast cancer: a systematic review and meta-analysis

View at publisher Summarise with VIRAT
Authors: Ali Benour, David P. Girgis, Gordon Richard Daly, Ayomide Michael Ade‐Conde, Gavin Paul Dowling, Cian M. Hehir, Gavin G. Calpin, Arnold D K Hill, Nuala Ann Healy, Leonie S. Young
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Aims This study aims to summarize the available data on the efficacy of minimally invasive ablative (MIA) therapies as the definitive treatment for primary localized breast cancer. Methods This systematic review and meta-anlysis was performed in accordance with PRISMA guidelines. Studies that applied MIA modalities such as radiofrequency ablation (RFA), cryoablation (CA), microwave ablation (MWA), and stereotactic body radiotherapy (SBRT) were included. Random effects meta-analyses were conducted to produce pooled local control (LC), recurrence-free survival (RFS), overall survival (OS), and breast-cancer-specific survival (BCSS). Results Our study summarized the results of 24 studies and 1112 patients. LCs at 1 year and 5 years were 94 and 96% for CA, 95 and 97% for RFA, 87 and 88% for SBRT. LCs for MWA were 94% at 1 year and 95% at 4 years. RFS at 1 year and 5 years was 93 and 97% for CA, 94 and 88% for RFA, 87 and 88% for SBRT, and lasty 95 and 90% for MWA at 1 year and 4 years. OS at 3 years was 91% for RFA, 94% for MWA, 97% for CA, and 91% for SBRT. BCSS at 3 years was 97% for CA, 89% for RFA, 91% for SBRT, and 94% for MWA. Conclusions The current evidence suggests MIA modalities are effective in producing sustained LC and strong survival outcomes in select patients with localized breast cancer. Future studies may elucidate the extent of their utility, particularly in those with small tumours and contraindications to surgery.

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas Hepatocellular Carcinoma Treatment and Prognosis

Publication details

Journal / source
British journal of surgery
Volume
113
Issue
Supplement_2
Publication date
1 March 2026
Language
EN